Nova Eye Medical Limited (EYE.AX)
AUD 0.16
(0.0%)
AUD 0.16
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.85 Million | -6.72 Million | -4.68 Million | -12.9 Million | 5.45 Million | -4.2 Million |
| Net Income | -8.79 Million | -15.29 Million | -7.49 Million | -4.35 Million | -10.32 Million | -5.77 Million |
| Depreciation & Amortization | 2.98 Million | 2.29 Million | 1.81 Million | 1.51 Million | 1.43 Million | 1.03 Million |
| Deferred income taxes | - | -4.5 Million | -2.11 Million | - | - | - |
| Stock-based compensation | 39 Thousand | 178 Thousand | 203 Thousand | - | - | - |
| Change in working capital | -2.05 Million | 191 Thousand | 2.38 Million | -10.12 Million | 18.19 Million | -4.3 Million |
| Other non-cash items | -38 Thousand | 10.41 Million | 521 Thousand | 59 Thousand | -3.85 Million | 4.83 Million |
| Investing Cash Flow | -325 Thousand | -800 Thousand | -4.57 Million | -3.21 Million | 88.25 Million | -3.49 Million |
| Investments in PPE | -449 Thousand | -800 Thousand | -5.59 Million | -2.22 Million | -1.66 Million | -726 Thousand |
| Acquisitions | - | - | 1.01 Million | -991 Thousand | 90.01 Million | 8000.00 |
| Investment purchases | - | - | - | - | -97 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | -88.57 Million | - |
| Other Investing Activities | -114 Thousand | -434 Thousand | -1 Million | -1.6 Million | 88.57 Million | -2.77 Million |
| Financing Cash Flow | 6.91 Million | 6.81 Million | -402 Thousand | -61.61 Million | -13.28 Million | -109 Thousand |
| Debt repayment | -518 Thousand | -653 Thousand | -402 Thousand | -582 Thousand | -12.3 Million | -933 Thousand |
| Dividends payments | - | - | - | -19.38 Million | - | - |
| Common Stock Repurchased | - | - | - | -41.64 Million | - | - |
| Common Stock Issuance | 7.43 Million | 7.47 Million | - | 41.64 Million | - | - |
| Other Financing Activities | -518 Thousand | -653 Thousand | -402 Thousand | -41.64 Million | -980 Thousand | 824 Thousand |
| Accounts receivables | -1.86 Million | -2000.00 | 1.81 Million | -1.61 Million | 14.39 Million | -829 Thousand |
| Accounts payables | -796 Thousand | 533 Thousand | 537 Thousand | -1.82 Million | -10.96 Million | 1.07 Million |
| Inventory | -477 Thousand | -266 Thousand | -639 Thousand | 33 Thousand | 3.77 Million | -3.47 Million |
| Other working capital | 281 Thousand | -74 Thousand | 675 Thousand | -6.71 Million | 10.98 Million | -1.07 Million |
| Cash at beginning of period | 7.41 Million | 8 Million | 17.8 Million | 95.64 Million | 15.37 Million | 23.06 Million |
| Cash at end of period | 6.15 Million | 7.41 Million | 8 Million | 17.8 Million | 95.64 Million | 15.18 Million |
| Capital Expenditure | -449 Thousand | -800 Thousand | -5.59 Million | -2.22 Million | -1.66 Million | -726 Thousand |
| Effect of forex changes on cash | 2000.00 | 123 Thousand | -140 Thousand | -112 Thousand | 47 Thousand | -77 Thousand |
| Net cash flow / Change in cash | -1.26 Million | -581 Thousand | -9.8 Million | -77.84 Million | 80.27 Million | -7.88 Million |
| Free Cash Flow | -8.3 Million | -7.52 Million | -10.27 Million | -15.13 Million | 3.79 Million | -4.93 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.79 Million | -3.16 Million | -5.62 Million | -8.68 Million | -15.29 Million | -6.6 Million |
| Depreciation & Amortization | 2.98 Million | 1.56 Million | 1.42 Million | 1.18 Million | 2.29 Million | 1.11 Million |
| Deferred income taxes | - | - | - | -2.18 Million | -4.5 Million | - |
| Stock-based compensation | - | 20 Thousand | 19 Thousand | 80 Thousand | 178 Thousand | 98 Thousand |
| Change in working capital | -1.96 Million | -2.05 Million | - | -61 Thousand | 191 Thousand | - |
| Other non-cash items | 9.14 Million | -103 Thousand | 2.92 Million | 7.73 Million | 10.41 Million | 3.13 Million |
| Investing Cash Flow | -449 Thousand | 29 Thousand | -354 Thousand | -280 Thousand | -800 Thousand | -520 Thousand |
| Investments in PPE | -449 Thousand | -17 Thousand | -354 Thousand | -280 Thousand | -800 Thousand | -520 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 46 Thousand | -160 Thousand | -36 Thousand | -434 Thousand | -433 Thousand |
| Financing Cash Flow | 6.91 Million | 7.24 Million | -334 Thousand | 7.1 Million | 6.81 Million | -288 Thousand |
| Debt repayment | - | - | -334 Thousand | - | -653 Thousand | -288 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.43 Million | 7.43 Million | - | 7.47 Million | 7.47 Million | - |
| Other Financing Activities | - | 7.24 Million | - | 7.1 Million | -653 Thousand | -288 Thousand |
| Accounts receivables | -1.86 Million | -1.86 Million | - | -2000.00 | -2000.00 | - |
| Accounts payables | -796 Thousand | - | - | - | 533 Thousand | - |
| Inventory | -477 Thousand | -477 Thousand | - | -266 Thousand | -266 Thousand | - |
| Other working capital | 1.16 Million | 281 Thousand | - | 207 Thousand | -74 Thousand | - |
| Cash at beginning of period | 7.41 Million | 2.61 Million | 7.41 Million | 2.63 Million | 8 Million | 8 Million |
| Cash at end of period | 6.15 Million | 6.15 Million | 2.61 Million | 7.41 Million | 7.41 Million | 2.63 Million |
| Capital Expenditure | -449 Thousand | -17 Thousand | -354 Thousand | -280 Thousand | -800 Thousand | -520 Thousand |
| Effect of forex changes on cash | - | 2000.00 | 7.41 Million | 100 Thousand | 123 Thousand | 23 Thousand |
| Net cash flow / Change in cash | -1.26 Million | 3.53 Million | -4.8 Million | 4.78 Million | -581 Thousand | -5.36 Million |
| Free Cash Flow | -8.18 Million | -3.75 Million | -4.47 Million | -2.42 Million | -7.52 Million | -5.1 Million |
ARIES
SUNS
CPMV
3501
3522
SKA-B